HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.300
+0.175 (5.60%)
Sep 18, 2026, 3:55 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.89 billion as of September 18, 2026. Its market cap has decreased by -21.05% in one year.
Market Cap
1.89B
Enterprise Value
1.70B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
ChartMarket Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.89B, a decrease of -70.42%. That is a compound annual growth rate of -35.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.89B | 11.86% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.27B |
| Antengene Corporation | 2.25B |
| Frontage Holdings | 2.10B |
| AIM Vaccine | 1.98B |
| Guangzhou Innogen Pharmaceutical Group | 1.76B |
| Mabpharm | 1.61B |
| SinoMab BioScience | 1.56B |
| Shandong Boan Biotechnology | 1.52B |